Richard Manning, PhD

Managing Director

Dr. Richard Manning’s expertise includes economic valuation and damages, intellectual property, breach of contract, fraud, and other commercial litigation. He provides testimony and consultation in all these areas and on securities litigation, tax, antitrust and competition, and public policy.

Richard Manning provides insights based on economic theory and data analysis to help clients solve complex problems arising in a variety of business settings with an emphasis on biopharmaceuticals in both prescription and OTC settings, medical devices, life sciences, and animal health.

Dr. Manning has testified in U.S. District Court, U.S. Bankruptcy Court, the Delaware Court of Chancery, the United States Patent Trial and Appeals Board, and the International Chamber of Commerce. He has served as a consulting expert and prepared reports and commentary on a wide range of issues in the biopharmaceutical (both innovative and follow-on sectors) and healthcare industries. His career includes 14 years as an executive in multinational pharmaceutical companies, where he led economic analysis and strategy development to shape practices on emerging business concerns.

Examples of Dr. Manning’s work include:

  • Economic analysis and strategy in litigation and business settings relative to pricing, reimbursement, marketing, manufacturing, R&D investments, and intellectual property protection, including commercial success, Paragraph IV, and reverse settlements.
  • Economic valuation of early-stage companies and strategic investments; evaluating mergers and acquisitions; industry profitability and other financial analyses.
  • Analyzing healthcare benefit design; healthcare system reforms; FDA regulatory reform, including biosimilars review processes, and product safety.

Before joining Secretariat, Dr. Manning was a managing director at Intensity. Previously, he was a partner at Bates White, an economic consulting firm offering analysis and expert testimony services to law firms, Fortune 500 companies, and government agencies. Dr. Manning was executive director at Merck, a senior director at Pfizer, and a director at PricewaterhouseCoopers.

Dr. Manning was an economics professor at Brigham Young University and a visiting professor at the Graduate School of Business at the University of Chicago. As an academic, his teaching and research focused on price theory, the economic analysis of law, industrial organization, and the economics of government regulation.

Related Insights

Talk to Our Insightful Experts